Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
121 participants
OBSERVATIONAL
2020-03-01
2021-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicentric Study of Coronavirus Disease 2019 (COVID-2019) in Solid Organ Transplant Recipients
NCT04319172
Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation
NCT04376775
Covid Vaccination in Liver Transplantation
NCT05079165
Liver Transplantation and Coronavirus Disease 2019 (COVID-19)
NCT04695756
Solid Organ Transplant Recipients With SARS-CoV-2 French Registry
NCT04360707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
While the outcomes of viral infections in solid organ transplant (SOT) recipients tend to be worse than those from the general population due to chronic immunosuppression, there is little information on the incidence and outcomes of COVID-19 in liver transplant (LT) recipients. LT recipients are usually under less immunosuppression than other SOT and the clinical expression and outcomes of COVID-19 may be different to the reported outcomes in other SOT.
The Spanish Society of Liver Transplantation, which includes 25 LT programs, has promoted a nationwide registry for LT with COVID-19 to help ascertain the incidence and outcomes and help evidence-based management .
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19
Liver Transplant recipients
Observational only
Observational Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observational only
Observational Study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed (PCR positive) SARS-Cov-2 infection
* Informed Consent
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sociedad Española de Trasplante Hepático
NETWORK
Hospital Clinic of Barcelona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jordi Colmenero
Liver Transplant Hepatologist, SETH Scientific Committee Chair
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jordi Colmenero
Role: PRINCIPAL_INVESTIGATOR
Sociedad Española de Trasplante Hepático
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SETH-affiliated Liver Transplant Programs in Spain
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
SETH webpage
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB/2020/0384
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.